phase readout
saveNCT07355283: IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma
NOT_YET_RECRUITINGupdated 5d ago
community read0 votes
Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc.. Phase: PHASE3. Conditions: Relapsed/Refractory Follicular Lymphoma
view source ↗
comments(0)
5-min edit window · permanent after that